Dendrimers for drug delivery

Due to their nanometric size, dendrimers have been considered as potentially suitable as new vehicles for drug delivery since their infancy. The association of a dendrimer and a drug may occur in different ways, either through covalent or non-covalent interactions. A non-covalent interaction can be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of materials chemistry. B, Materials for biology and medicine Materials for biology and medicine, 2014-01, Vol.2 (26), p.4055-4066
Hauptverfasser: Caminade, Anne-Marie, Turrin, Cédric-Olivier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4066
container_issue 26
container_start_page 4055
container_title Journal of materials chemistry. B, Materials for biology and medicine
container_volume 2
creator Caminade, Anne-Marie
Turrin, Cédric-Olivier
description Due to their nanometric size, dendrimers have been considered as potentially suitable as new vehicles for drug delivery since their infancy. The association of a dendrimer and a drug may occur in different ways, either through covalent or non-covalent interactions. A non-covalent interaction can be the simple encapsulation inside dendrimers that enhances the solubility of lipophilic drugs in water, or electrostatic interactions between the surface and charged drugs (or DNA, RNA, or siRNA). The covalent association may occur through stable bonds, in particular for dendrimers that are considered as active per se, or through cleavable bonds that should be cleaved only when reaching the target (often cancerous cells). In addition, the full structure of the dendrimer can be disassembled under the influence of a trigger such as pH variations. This review will present these strategies and their consequences for drug delivery.
doi_str_mv 10.1039/c4tb00171k
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02007939v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1660410406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c494t-b9c3b0dfe0404703192d4595b5fac95265eb09a3fcb2391188a625e08b17c1a33</originalsourceid><addsrcrecordid>eNqFkc1PwkAQxTdGIwa5eDaGo5pUZ_aru0fED4wkXjDxttlut1otFHcpCf-9RZArc5nJ5JeXN_MIOUO4QWD61vFFBoApfh-QEwoCklSgOtzN8N4hvRi_oC2FUjF-TDqMUokpkyfk_N7P8lBOfYj9og79PDQf_dxX5dKH1Sk5KmwVfW_bu-Tt8WEyHCXj16fn4WCcOK75Ism0YxnkhQcOPAWGmuZcaJGJwjotqBQ-A21Z4TLKNKJSVlLhQWWYOrSMdcnVRvfTVmbeurFhZWpbmtFgbNY7oACpZnqJLXu5Yeeh_ml8XJhpGZ2vKjvzdRMNZSqVCpHKvWj7AQAJQsF-VErg2N63Vr3eoC7UMQZf7BwjmHUkZsgnd3-RvLTwxVa3yaY-36H_AbBf0QqBZQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1660410406</pqid></control><display><type>article</type><title>Dendrimers for drug delivery</title><source>Alma/SFX Local Collection</source><source>Royal Society of Chemistry E-Journals</source><creator>Caminade, Anne-Marie ; Turrin, Cédric-Olivier</creator><creatorcontrib>Caminade, Anne-Marie ; Turrin, Cédric-Olivier</creatorcontrib><description>Due to their nanometric size, dendrimers have been considered as potentially suitable as new vehicles for drug delivery since their infancy. The association of a dendrimer and a drug may occur in different ways, either through covalent or non-covalent interactions. A non-covalent interaction can be the simple encapsulation inside dendrimers that enhances the solubility of lipophilic drugs in water, or electrostatic interactions between the surface and charged drugs (or DNA, RNA, or siRNA). The covalent association may occur through stable bonds, in particular for dendrimers that are considered as active per se, or through cleavable bonds that should be cleaved only when reaching the target (often cancerous cells). In addition, the full structure of the dendrimer can be disassembled under the influence of a trigger such as pH variations. This review will present these strategies and their consequences for drug delivery.</description><identifier>ISSN: 2050-750X</identifier><identifier>EISSN: 2050-7518</identifier><identifier>DOI: 10.1039/c4tb00171k</identifier><identifier>PMID: 32261736</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Chemical Sciences ; Coordination chemistry ; Covalence ; Dendrimers ; Drug delivery systems ; Drugs ; Electrostatics ; Nanostructure ; Ribonucleic acids ; Strategy</subject><ispartof>Journal of materials chemistry. B, Materials for biology and medicine, 2014-01, Vol.2 (26), p.4055-4066</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c494t-b9c3b0dfe0404703192d4595b5fac95265eb09a3fcb2391188a625e08b17c1a33</citedby><cites>FETCH-LOGICAL-c494t-b9c3b0dfe0404703192d4595b5fac95265eb09a3fcb2391188a625e08b17c1a33</cites><orcidid>0000-0001-7187-8070 ; 0000-0001-8487-3578</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32261736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-02007939$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Caminade, Anne-Marie</creatorcontrib><creatorcontrib>Turrin, Cédric-Olivier</creatorcontrib><title>Dendrimers for drug delivery</title><title>Journal of materials chemistry. B, Materials for biology and medicine</title><addtitle>J Mater Chem B</addtitle><description>Due to their nanometric size, dendrimers have been considered as potentially suitable as new vehicles for drug delivery since their infancy. The association of a dendrimer and a drug may occur in different ways, either through covalent or non-covalent interactions. A non-covalent interaction can be the simple encapsulation inside dendrimers that enhances the solubility of lipophilic drugs in water, or electrostatic interactions between the surface and charged drugs (or DNA, RNA, or siRNA). The covalent association may occur through stable bonds, in particular for dendrimers that are considered as active per se, or through cleavable bonds that should be cleaved only when reaching the target (often cancerous cells). In addition, the full structure of the dendrimer can be disassembled under the influence of a trigger such as pH variations. This review will present these strategies and their consequences for drug delivery.</description><subject>Chemical Sciences</subject><subject>Coordination chemistry</subject><subject>Covalence</subject><subject>Dendrimers</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Electrostatics</subject><subject>Nanostructure</subject><subject>Ribonucleic acids</subject><subject>Strategy</subject><issn>2050-750X</issn><issn>2050-7518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkc1PwkAQxTdGIwa5eDaGo5pUZ_aru0fED4wkXjDxttlut1otFHcpCf-9RZArc5nJ5JeXN_MIOUO4QWD61vFFBoApfh-QEwoCklSgOtzN8N4hvRi_oC2FUjF-TDqMUokpkyfk_N7P8lBOfYj9og79PDQf_dxX5dKH1Sk5KmwVfW_bu-Tt8WEyHCXj16fn4WCcOK75Ism0YxnkhQcOPAWGmuZcaJGJwjotqBQ-A21Z4TLKNKJSVlLhQWWYOrSMdcnVRvfTVmbeurFhZWpbmtFgbNY7oACpZnqJLXu5Yeeh_ml8XJhpGZ2vKjvzdRMNZSqVCpHKvWj7AQAJQsF-VErg2N63Vr3eoC7UMQZf7BwjmHUkZsgnd3-RvLTwxVa3yaY-36H_AbBf0QqBZQ</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Caminade, Anne-Marie</creator><creator>Turrin, Cédric-Olivier</creator><general>Royal Society of Chemistry</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>JG9</scope><scope>L7M</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-7187-8070</orcidid><orcidid>https://orcid.org/0000-0001-8487-3578</orcidid></search><sort><creationdate>20140101</creationdate><title>Dendrimers for drug delivery</title><author>Caminade, Anne-Marie ; Turrin, Cédric-Olivier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c494t-b9c3b0dfe0404703192d4595b5fac95265eb09a3fcb2391188a625e08b17c1a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Chemical Sciences</topic><topic>Coordination chemistry</topic><topic>Covalence</topic><topic>Dendrimers</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Electrostatics</topic><topic>Nanostructure</topic><topic>Ribonucleic acids</topic><topic>Strategy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caminade, Anne-Marie</creatorcontrib><creatorcontrib>Turrin, Cédric-Olivier</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of materials chemistry. B, Materials for biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caminade, Anne-Marie</au><au>Turrin, Cédric-Olivier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dendrimers for drug delivery</atitle><jtitle>Journal of materials chemistry. B, Materials for biology and medicine</jtitle><addtitle>J Mater Chem B</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>2</volume><issue>26</issue><spage>4055</spage><epage>4066</epage><pages>4055-4066</pages><issn>2050-750X</issn><eissn>2050-7518</eissn><abstract>Due to their nanometric size, dendrimers have been considered as potentially suitable as new vehicles for drug delivery since their infancy. The association of a dendrimer and a drug may occur in different ways, either through covalent or non-covalent interactions. A non-covalent interaction can be the simple encapsulation inside dendrimers that enhances the solubility of lipophilic drugs in water, or electrostatic interactions between the surface and charged drugs (or DNA, RNA, or siRNA). The covalent association may occur through stable bonds, in particular for dendrimers that are considered as active per se, or through cleavable bonds that should be cleaved only when reaching the target (often cancerous cells). In addition, the full structure of the dendrimer can be disassembled under the influence of a trigger such as pH variations. This review will present these strategies and their consequences for drug delivery.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>32261736</pmid><doi>10.1039/c4tb00171k</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-7187-8070</orcidid><orcidid>https://orcid.org/0000-0001-8487-3578</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2050-750X
ispartof Journal of materials chemistry. B, Materials for biology and medicine, 2014-01, Vol.2 (26), p.4055-4066
issn 2050-750X
2050-7518
language eng
recordid cdi_hal_primary_oai_HAL_hal_02007939v1
source Alma/SFX Local Collection; Royal Society of Chemistry E-Journals
subjects Chemical Sciences
Coordination chemistry
Covalence
Dendrimers
Drug delivery systems
Drugs
Electrostatics
Nanostructure
Ribonucleic acids
Strategy
title Dendrimers for drug delivery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T20%3A50%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dendrimers%20for%20drug%20delivery&rft.jtitle=Journal%20of%20materials%20chemistry.%20B,%20Materials%20for%20biology%20and%20medicine&rft.au=Caminade,%20Anne-Marie&rft.date=2014-01-01&rft.volume=2&rft.issue=26&rft.spage=4055&rft.epage=4066&rft.pages=4055-4066&rft.issn=2050-750X&rft.eissn=2050-7518&rft_id=info:doi/10.1039/c4tb00171k&rft_dat=%3Cproquest_hal_p%3E1660410406%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1660410406&rft_id=info:pmid/32261736&rfr_iscdi=true